930-P: Efficacy of Oral Semaglutide According to Race: An Exploratory Subgroup Analysis of the PIONEER Trial Program von DESOUZA, CYRUS, AMOD, ASLAM, KALLENBACH, KLAUS, LIN, PETER J., NIELSEN, MORTEN ABILDLUND, SØRRIG, RASMUS, MONTANYA, EDUARD

Volltext

964-P: Glycemic and Body Weight Responses to Oral Semaglutide in the PIONEER Trial Program von DUNGAN, KATHLEEN M., HERTZ, CHRISTIN L., MELLBIN, LINDA, NIELSEN, MORTEN ABILDLUND, SØRRIG, RASMUS, WOO, VINCENT C., VILSBØLL, TINA

Volltext

Abstract 138: Efficacy of oral semaglutide according to race: An exploratory subgroup analysis of the PIONEER trial program von Srivastava, Kunal, Desouza, Cyrus, Amod, Aslam, Kallenbach, Klaus, Lin, Peter J, Nielsen, Morten Abildlund

Volltext

Abstract 34: Time spent in glycemic control after initiating treatment with oral semaglutide versus empagliflozin: An exploratory analysis of the PIONEER 2 trial von Prakash, Prashanth S, Rosenstock, Julio, Cariou, Bertrand, Christiansen, Erik, Hertz, Christin l, Montanya, Eduard, Nielsen, Morten Abildlund, Knop, Filip K

Volltext

Abstract 15: Glycemic and body weight responses to oral semaglutide in the PIONEER trial program von Kumar, K B Sharan, Dungan, Kathleen M, Hertz, Christin L, Mellibin, Linda, Nielsen, Morten Abildlund, Sorrig, Rasmus, Woo, Vincent C, Vilsboll, Tina

Volltext

Efficacy of Semaglutide vs. Dulaglutide Across Baseline HbA1C in SUSTAIN 7 von Wrzal, Paulina K., Pratley, Richard E., Frias, Juan P., Kumar, Harish, Petrie, John, Navarria, Andrea, Nielsen, Morten Abildlund, Schmidt, Wolfgang E.

Volltext

126 - Efficacy of Semaglutide vs. Dulaglutide Across Baseline HbA1C in SUSTAIN 7 von Wrzal, Paulina K., Pratley, Richard E., Frias, Juan P., Kumar, Harish, Petrie, John, Navarria, Andrea, Nielsen, Morten Abildlund, Schmidt, Wolfgang E.

Volltext

670-P: Time Spent in Glycemic Control after Initiating Treatment with Oral Semaglutide vs. Empagliflozin: An Exploratory Analysis of the PIONEER 2 Trial von ROSENSTOCK, JULIO, CARIOU, BERTRAND, CHRISTIANSEN, ERIK, HERTZ, CHRISTIN L., MONTANYA, EDUARD, NIELSEN, MORTEN ABILDLUND, KNOP, FILIP K.

Volltext

Efficacy of Semaglutide vs. Dulaglutide across Baseline HbA1c in SUSTAIN 7 von PRATLEY, RICHARD E., FRIAS, JUAN P., KUMAR, HARISH, PETRIE, JOHN, NAVARRIA, ANDREA, NIELSEN, MORTEN ABILDLUND, SCHMIDT, WOLFGANG E.

Volltext

A phase 1, randomized, double‐blind, placebo‐controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability of oral semaglutide in healthy Chinese s... von Xie, Panpan, Abildlund, Morten T., Bækdal, Tine A., He, Xuemei, Lyauk, Yassine K., Patted, Usha Rani H., Ning, Zu, Shi, Aixin

Volltext

Abstract 34: Time spent in glycemic control after initiating treatment with oral semaglutide versus empagliflozin: An exploratory analysis of the PIONEER 2 trial

Volltext

Abstract 15: Glycemic and body weight responses to oral semaglutide in the PIONEER trial program

Volltext

Abstract 138: Efficacy of oral semaglutide according to race: An exploratory subgroup analysis of the PIONEER trial program

Volltext